Clinical Trial Update: Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial evaluating mitazalimab in combination with chemotherapy for metastatic pancreatic ductal adenocarcinoma, focusi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Mitazalimab (mitazalimab)

Snippet

Sponsor: Alligator Bioscience AB | Conditions: Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING